Treatment of vitamin D deficiency/insufficiency with ergocalciferol is associated with reduced vascular access dysfunction in chronic hemodialysis patients

Gaurav Agarwal; Karina Vasquez; Neena Penagaluru; Jonathan A Gelfond; Wajeh Y Qunibi

doi:10.1111/hdi.12292

Treatment of vitamin D deficiency/insufficiency with ergocalciferol is associated with reduced vascular access dysfunction in chronic hemodialysis patients

Gaurav Agarwal, Karina Vasquez, Neena Penagaluru, Jonathan A Gelfond, Wajeh Y Qunibi

Research output: Contribution to journal › Article › peer-review

7 Scopus citations

Abstract

Vitamin D deficiency or insufficiency is highly prevalent among patients with chronic kidney disease (CKD). This study aims to determine the relationship between vitamin D and frequency of vascular access dysfunction (VAD) in hemodialysis (HD) patients. We reviewed medical records of all HD patients who had serum 25-hydroxyvitamin D (25OHD) levels at 4 outpatient dialysis facilities between January 2011 and January 2012. Patients were included if they were ≥18 years of age, had been on maintenance dialysis for ≥3 months, and had native arteriovenous fistula or synthetic polytetrafluoroethylene grafts for dialysis access. Patients with catheters were excluded. 25-Hydroxyvitamin D levels

Original language	English (US)
Pages (from-to)	499-508
Number of pages	10
Journal	Hemodialysis International
Volume	19
Issue number	4
DOIs	https://doi.org/10.1111/hdi.12292
State	Published - Oct 1 2015

Keywords

Access
Cardiovascular disease
Dialysis
Ergocalciferol
Vitamin D

ASJC Scopus subject areas

Hematology
Nephrology

Access to Document

10.1111/hdi.12292

Cite this

Treatment of vitamin D deficiency/insufficiency with ergocalciferol is associated with reduced vascular access dysfunction in chronic hemodialysis patients. / Agarwal, Gaurav; Vasquez, Karina; Penagaluru, Neena; Gelfond, Jonathan A ; Qunibi, Wajeh Y.

In: Hemodialysis International, Vol. 19, No. 4, 01.10.2015, p. 499-508.

Research output: Contribution to journal › Article › peer-review

@article{7b38fff5ebbd4b5cbadfa509b50317aa,

title = "Treatment of vitamin D deficiency/insufficiency with ergocalciferol is associated with reduced vascular access dysfunction in chronic hemodialysis patients",

abstract = "Vitamin D deficiency or insufficiency is highly prevalent among patients with chronic kidney disease (CKD). This study aims to determine the relationship between vitamin D and frequency of vascular access dysfunction (VAD) in hemodialysis (HD) patients. We reviewed medical records of all HD patients who had serum 25-hydroxyvitamin D (25OHD) levels at 4 outpatient dialysis facilities between January 2011 and January 2012. Patients were included if they were ≥18 years of age, had been on maintenance dialysis for ≥3 months, and had native arteriovenous fistula or synthetic polytetrafluoroethylene grafts for dialysis access. Patients with catheters were excluded. 25-Hydroxyvitamin D levels ",

keywords = "Access, Cardiovascular disease, Dialysis, Ergocalciferol, Vitamin D",

author = "Gaurav Agarwal and Karina Vasquez and Neena Penagaluru and Gelfond, {Jonathan A} and Qunibi, {Wajeh Y}",

year = "2015",

month = oct,

day = "1",

doi = "10.1111/hdi.12292",

language = "English (US)",

volume = "19",

pages = "499--508",

journal = "Hemodialysis International",

issn = "1492-7535",

publisher = "Wiley-Blackwell",

number = "4",

}

TY - JOUR

T1 - Treatment of vitamin D deficiency/insufficiency with ergocalciferol is associated with reduced vascular access dysfunction in chronic hemodialysis patients

AU - Agarwal, Gaurav

AU - Vasquez, Karina

AU - Penagaluru, Neena

AU - Gelfond, Jonathan A

AU - Qunibi, Wajeh Y

PY - 2015/10/1

Y1 - 2015/10/1

N2 - Vitamin D deficiency or insufficiency is highly prevalent among patients with chronic kidney disease (CKD). This study aims to determine the relationship between vitamin D and frequency of vascular access dysfunction (VAD) in hemodialysis (HD) patients. We reviewed medical records of all HD patients who had serum 25-hydroxyvitamin D (25OHD) levels at 4 outpatient dialysis facilities between January 2011 and January 2012. Patients were included if they were ≥18 years of age, had been on maintenance dialysis for ≥3 months, and had native arteriovenous fistula or synthetic polytetrafluoroethylene grafts for dialysis access. Patients with catheters were excluded. 25-Hydroxyvitamin D levels

AB - Vitamin D deficiency or insufficiency is highly prevalent among patients with chronic kidney disease (CKD). This study aims to determine the relationship between vitamin D and frequency of vascular access dysfunction (VAD) in hemodialysis (HD) patients. We reviewed medical records of all HD patients who had serum 25-hydroxyvitamin D (25OHD) levels at 4 outpatient dialysis facilities between January 2011 and January 2012. Patients were included if they were ≥18 years of age, had been on maintenance dialysis for ≥3 months, and had native arteriovenous fistula or synthetic polytetrafluoroethylene grafts for dialysis access. Patients with catheters were excluded. 25-Hydroxyvitamin D levels

KW - Access

KW - Cardiovascular disease

KW - Dialysis

KW - Ergocalciferol

KW - Vitamin D

UR - http://www.scopus.com/inward/record.url?scp=84943353428&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84943353428&partnerID=8YFLogxK

U2 - 10.1111/hdi.12292

DO - 10.1111/hdi.12292

M3 - Article

C2 - 25790374

AN - SCOPUS:84943353428

VL - 19

SP - 499

EP - 508

JO - Hemodialysis International

JF - Hemodialysis International

SN - 1492-7535

IS - 4

ER -

Treatment of vitamin D deficiency/insufficiency with ergocalciferol is associated with reduced vascular access dysfunction in chronic hemodialysis patients

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this